Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling.

Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, CNY 8301, 149 13th Street, Charlestown, MA 02129, USA.
American Journal of Respiratory Cell and Molecular Biology (Impact Factor: 4.11). 02/2009; 41(4):397-406. DOI: 10.1165/rcmb.2008-0415OC
Source: PubMed

ABSTRACT Obesity is associated with an increased incidence and severity of asthma, as well as other lung disorders, such as pulmonary hypertension. Adiponectin (APN), an antiinflammatory adipocytokine, circulates at lower levels in the obese, which is thought to contribute to obesity-related inflammatory diseases. We sought to determine the effects of APN deficiency in a murine model of chronic asthma. Allergic airway inflammation was induced in APN-deficient mice (APN(-/-)) using sensitization without adjuvant followed by airway challenge with ovalbumin. The mice were then analyzed for changes in inflammation and lung remodeling. APN(-/-) mice in this model develop increased allergic airway inflammation compared with wild-type mice, with greater accumulation of eosinophils and monocytes in the airways associated with elevated lung chemokine levels. Surprisingly, APN(-/-) mice developed severe pulmonary arterial muscularization and pulmonary arterial hypertension in this model, whereas wild-type mice had only mild vascular remodeling and comparatively less pulmonary arterial hypertension. Our findings demonstrate that APN modulates allergic inflammation and pulmonary vascular remodeling in a model of chronic asthma. These data provide a possible mechanism for the association between obesity and asthma, and suggest a potential novel link between obesity, inflammatory lung disease, and pulmonary hypertension.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Major features of allergic asthma include airway hyperresponsiveness (AHR), eosinophilic inflammation, and goblet cell metaplasia. Rho kinase (ROCK) is a serine/threonine protein kinase that regulates the actin cytoskeleton. By doing so, it can modulate airway smooth muscle cell contraction and leukocyte migration and proliferation. This study was designed to determine the contributions of the two ROCK isoforms, ROCK1 and ROCK2, to AHR, inflammation and goblet cell metaplasia in a mast-cell dependent model of allergic airways disease.Methods and ResultsRepeated intranasal challenges with OVA caused AHR, eosinophilic inflammation, and goblet cell hyperplasia in wildtype (WT) mice. OVA- induced AHR was partially or completely abrogated in mice haploinsufficient for ROCK2 (ROCK2+/-) or ROCK1 (ROCK1+/-), respectively. In contrast, there was no effect of ROCK insufficiency on allergic airways inflammation, although both ROCK1 and ROCK2 insufficiency attenuated mast cell degranulation. Goblet cell hyperplasia, as indicated by PAS staining, was not different in ROCK1+/- versus WT mice. However, in ROCK2+/- mice, goblet cell hyperplasia was reduced in medium but not large airways. Maximal acetylcholine-induced force generation was reduced in tracheal rings from ROCK1+/- and ROCK2+/- versus WT mice. The ROCK inhibitor, fasudil, also reduced airway responsiveness in OVA-challenged mice, without affecting inflammatory responses.Conclusion In a mast cell model of allergic airways disease, ROCK1 and ROCK2 both contribute to AHR, likely through direct effects on smooth muscle cell and effects on mast-cell degranulation. In addition, ROCK2 but not ROCK1 plays a role in allergen-induced goblet cell hyperplasia.This article is protected by copyright. All rights reserved.
    Clinical & Experimental Allergy 10/2014; DOI:10.1111/cea.12438 · 4.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intrauterine growth restriction (IUGR) dramatically increases the risk of bronchopulmonary dysplasia in preterm babies, a disease characterised by arrested alveolarisation and abnormal microvascular angiogenesis. We have previously described a rodent low protein diet (LPD) model of IUGR inducing impaired alveolarisation, but failed to demonstrate any modification of the classical factors involved in lung development. We performed a genome-wide microarray analysis in 120 rat pups with LPD-induced IUGR and their controls, at three key time-points of the alveolarisation process: postnatal day 4 (P4): start of alveolarisation; P10: peak of the alveolarisation process and P21: end of the alveolarisation process. Results were analysed using Arraymining, DAVID and KEGG software and validated by RT-qPCR and Western blots. Considering a cut-off of 2:1 as significant: 67 transcripts at P4, 102 transcripts at P10 and 451 transcripts at P21 were upregulated; 89 transcripts at P4, 25 transcripts at P10 and 585 transcripts at P21 were downregulated. Automatic functional classification identified three main modified pathways: “cell adhesion molecules”, “cardiac muscle contraction” and “peroxisome proliferator-activated receptor” (PPAR). Protein analysis confirmed involvement of the PPAR pathway, with an increase of FABP4, an activator of this pathway, at P4 and an increase of adiponectin at P21. Other data also suggest involvement of the PPAR pathway in impaired alveolarisation. Our results show that deregulation of the PPAR pathway may be an important component of the mechanism inducing impaired alveolarisation observed in IUGR.
    The Journal of Pathology 10/2014; 235(3). DOI:10.1002/path.4470 · 7.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is a major risk factor for asthma. Likewise, obesity is known to increase disease severity in asthmatic subjects and also to impair the efficacy of first-line treatment medications for asthma, worsening asthma control in obese patients. This concept is in agreement with the current understanding that some asthma phenotypes are not accompanied by detectable inflammation, and may not be ameliorated by classical anti-inflammatory therapy. There are growing evidences suggesting that the obesity-related asthma phenotype does not necessarily involve the classical TH2-dependent inflammatory process. Hormones involved in glucose homeostasis and in the pathogeneses of obesity likely directly or indirectly link obesity and asthma through inflammatory and non-inflammatory pathways. Furthermore, the endocrine regulation of the airway-related pre-ganglionic nerves likely contributes to airway hyperreactivityity (AHR) in obese states. In this review, we focused our efforts on understanding the mechanism underlying obesity-related asthma by exploring the TH2-independent mechanisms leading to this disease.
    Metabolism 10/2014; 64(2). DOI:10.1016/j.metabol.2014.10.002 · 3.61 Impact Factor


Available from